Publikationen von F. Ohl

Thoeringer, C. K.; Erhardt, A.; Sillaber, I.; Mueller, M. B.; Ohl, F.; Holsboer, F.; Keck, M. E.: Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. Journal of Psychopharmacology 24 (5), S. 733 - 743 (2010)

Rammes, G.; Starker, L. K.; Haseneder, R.; Berkmann, J.; Plack, A.; Zieglgänsberger, W.; Ohl, F.; Kochs, E. F.; Blobner, M.: Isoflurane anaesthesia reversibly improves cognitive function and long-term potentiation (LTP) via an up-regulation in NMDA receptor 2B subunit expression. Neuropharmacology 56 (3), S. 626 - 636 (2009)

Erhardt, A.; Müller, M. B.; Rödel, A.; Welt, T.; Ohl, F.; Holsboer, F.; Keck, M. E.: Consequences of chronic social stress on behaviour and vasopressin gene expression in the PVN of DBA/2OlaHsd mice-influence of treatment with the CRHR1-antagonist R121919/NBI 30775. Journal of Psychopharmacology 23 (1), S. 31 - 39 (2009)

Sillaber, I.; Panhuysen, M.; Henniger, M. S. H.; Ohl, F.; Kühne, C.; Pütz, B.; Pohl, T.; Deussing, J. M.; Paez-Pereda, M.; Holsboer, F.: Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology 200 (4), S. 557 - 572 (2008)

Thoeringer, C. K.; Sillaber, I.; Roedel, A.; Erhardt, A.; Mueller, M. B.; Ohl, F.; Holsboer, F.; Keck, M. E.: The temporal dynamics of intrahippocampal corticosterone in response to stress-related stimuli with different emotional and physical load: An in vivo microdialysis study in C57BL/6 and DBA/2 inbred mice. Psychoneuroendocrinology 32 (6), S. 746 - 757 (2007)

Roedel, A.; Storch, C.; Holsboer, F.; Ohl, F.: Effects of light or dark phase testing on behavioural and cognitive performance in DBA mice. Laboratory Animals 40 (4), S. 371 - 381 (2006)

Rujescu, D.; Bender, A.; Keck, M.; Hartmann, A. M.; Ohl, F.; Raeder, H.; Giegling, I.; Genius, J.; McCarley, R. W.; Möller, H. J. et al.; Grunze, H.: A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: Molecular, cellular, functional and Behavioral abnormalities. Biological Psychiatry 59 (8), S. 721 - 729 (2006)

Rujescu, D.; Giegling, I.; Hartmann, A. M.; Genius, J.; Grunze, H.; Bender, A.; Mulert, C.; Hegerl, U.; Muglia, P.; Birell, C. et al.; Ruppert, A.; Schon, S.; Meitinger, T.; Bettecken, T.; Keck, M.; Ohl, F.; Möller, H. J.: A complementary strategy to approach the genetics of schizophrenia. Schizophrenia Research 81 (Suppl. S), S. 63 - 64 (2006)

Schmidt, M. V.; Deussing, J. M.; Oitzl, M. S.; Ohl, F.; Levine, S.; Wurst, W.; Holsboer, F.; Müller, M. B.; de Kloet, E. R.: Differential disinhibition of the neonatal hypothalamic-pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice. European Journal of Neuroscience 24, S. 2291 - 2298 (2006)

Welt, T.; Rödel, A.; Ohl, F.; Erhardt, A.; Keck, M. E.: The explorative-reduced (EXR002) C3H mice - a new mouse model of depression? Pharmacopsychiatry 38 (5), S. 284 - 284 (2005)

Gailus-Durner, V.; Fuchs, H.; Becker, L.; Bolle, I.; Brielmeier, M.; Calzada-Wack, J.; Evert, R.; Ehrhardt, N.; Dalkel, C.; Franz, T. J. et al.; Grundner-Culemann, E.; Hammelbacher, S.; Hölter, S. M.; Hölzlwimmer, G.; Horsch, M.; Javaheri, A.; Kataydjiev, S. V.; Klempt, M.; Kling, E.; Kunder, S.; Lengger, C.; Lisse, T.; Mijalski, T.; Naton, B.; Pedersen, V.; Prehn, C.; Przemeck, G.; Racz, I.; Reinhard, C.; Reitmeir, P.; Schneider, I.; Schrewe, A.; Steinkamp, R.; Zybill, C.; Adamski, J.; Beckers, J.; Behrendt, H.; Favor, J.; Graw, J.; Heldmaier, G.; Höfler, H.; Ivandic, B.; Katus, H.; Kirchhof, P.; Klingenspor, M.; Klopstock, T.; Lengeling, A.; Müller, W.; Ohl, F.; Ollert, M.; Quintanilla-Martinez, L.; Schmidt, J.; Schulz, H.; Wolf, E.; Wurst, W.; Zimmer, A.; Busch, D. H.; de Angelis, M. H.: Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nature Methods 2 (6), S. 403 - 404 (2005)

Keck, M. E.; Sartori, S. B.; Welt, T.; Müller, M. B.; Ohl, F.; Holsboer, F.; Landgraf, R.; Singewald, N.: Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. Journal of Neurochemistry 92 (5), S. 1170 - 1179 (2005)

Keck, M. E.; Ohl, F.; Holsboer, F.; Müller, M. B.: Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neuroscience and Biobehavioral Reviews 29 (4-5 Sp. Iss.), S. 867 - 889 (2005)

Post, A.; Ohl, F.; Almeida, O. F. X.; Binder, E. B.; Rücker, M.; Welt, S.; Binder, E.; Holsboer, F.; Sillaber, I.: Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). Psychopharmacology 180, S. 150 - 158 (2005)

Schmidt, M. V.; Oitzl, M. S.; Müller, M. B.; Ohl, F.; Wurst, W.; Holsboer, F.; Levine, S.; De Kloet, E. R.: Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice (vol 119, pg 589, 2003). Neuroscience 135 (4), S. 1343 - 1343 (2005)

Binder, E.; Droste, S. K.; Ohl, F.; Reul, J. M. H. M.: Regular voluntary exercise reduces anxiety-related behaviour and impulsiveness in mice. Behavioural Brain Research 155 (2), S. 197 - 206 (2004)

Storch, C.; Höhne, A.; Holsboer, F.; Ohl, F.: Activity patterns as a correlate for sleep-wake behaviour in mice. Journal of Neuroscience Methods 133, S. 173 - 179 (2004)

Ohl, F.: Testing for anxiety. Clinical Neuroscience Research 3 (4-5), S. 233 - 238 (2003)

Ohl, F.; Keck, M. E.: Behavioural screening in mutagenised mice-in search for novel animal models of psychiatric disorders. European Journal of Pharmacology 480 (1-3), S. 219 - 228 (2003)

Deussing, J.; Breu, J.; Binder, E. B.; Ohl, F.; Holsboer, F.; Wurst, W.: Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides. Pharmacopsychiatry 36 (5), S. 221 - 221 (2003)